ABBOTT PARK, Ill., Aug. 18 (HSMN NewsFeed) — Abbott (NYSE: ABT ) announced today they have partnered with Velcera, Inc., a specialty laboratory company focused on pet health, to market the first canine pain management product delivered in a transmuc…
Biopharmaceuticals, Drug Delivery
Abbott, Velcera, meloxicam, Promist , transmucosal

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Abbott Announces Partnership with Velcera to Bring New Pain Medication for Dogs to Market”
Leave a Comment